Deep MedChem

Deep MedChem develops CHEESE, a family of AI products for early-stage drug discovery, including molecule search across 2D, 3D shape, electrostatic and activity similarity, a synthon-based search over 40T+ molecules, and a navigator tool for combinatorial chemical spaces.

The company serves drug discovery and medicinal chemistry teams, offering CHEESE through cloud or fully on-premises deployment, a public API, CLI, Python and KNIME integrations, and custom database indexing. The website also lists expert services derived from the platform; the business model appears to be software licensing and services, though pricing is not stated.

The company is registered in Prague, Czech Republic (a.s., founded 2023-12-15) and was described as a spin-off from The MAMA AI and i&i Prague, connected with IOCB Prague. The website cites a partner testimonial from IOCB Prague and lists eight database partners; it invites applications by sending a CV to jobs@deepmedchem.com.

Product: CHEESE, an AI virtual screening platform with molecular search (2D, 3D shape, electrostatics, activity), synthon-based trillion-scale search, and a combinatorial space navigator, offered on cloud or on-premises.